Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus metoclopramide for prevention of postoperative nausea and vomiting after strabismus surgery
IRCT201101052496N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron and metoclopramide in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Hemodynamic changes and Postoperative nausea and vomiting prevention. Started Mar 2009; status: completed.
02
Drugs
ondansetronmetoclopramide
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT201101052496N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201101052496N5.